Mudita Advisors LLP Maxcyte, Inc. Transaction History
Mudita Advisors LLP
- $279 Million
- Q2 2025
A detailed history of Mudita Advisors LLP transactions in Maxcyte, Inc. stock. As of the latest transaction made, Mudita Advisors LLP holds 3,370,689 shares of MXCT stock, worth $4.28 Million. This represents 2.64% of its overall portfolio holdings.
Number of Shares
3,370,689
Previous 3,328,441
1.27%
Holding current value
$4.28 Million
Previous $9.09 Million
19.13%
% of portfolio
2.64%
Previous 4.94%
Shares
12 transactions
Others Institutions Holding MXCT
# of Institutions
119Shares Held
70.9MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY8.91MShares$11.3 Million1.1% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$10.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY7MShares$8.89 Million0.0% of portfolio
-
Mirabella Financial Services LLP London, X06.6MShares$8.38 Million1.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$7.11 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $129M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...